Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.

Human cytomegalovirus (HCMV) interferes with cellular immune responses by modulating surface expression of MHC class I molecules. Here, we focused on HCMV-encoded unique short (US) 2 and US11, which bind newly synthesized MHC class I heavy chains (HCs) and support their dislocation into the cytosol for subsequent degradation by proteasomes. Not all MHC class I locus products are equally sensitive to this down-modulation. The aim of this study was to identify which domains, and ultimately which residues, are responsible for the resistance or sensitivity of MHC class I molecules to US2- and US11-mediated down-regulation. We show that, besides endoplasmic reticulum-lumenal regions, the C-terminus of class I molecules represents an important determinant for allele specificity in US11-mediated degradation. HLA-E becomes sensitive to US11-mediated down-regulation when its cytoplasmic tail is extended. Interestingly, this only requires two additional residues, lysine and valine, at its C-terminus. For US2, the MHC class I allele specificity is largely determined by a small region at the junction of the alpha2/alpha3 domain of the HC. It is quite remarkable that minor changes, in only four residues, can completely revert the sensitivity of naturally US2-resistant HLA-E molecules. With this study we provide better insights into the features underlying the selectivity in MHC class I down-regulation by US2 and US11.

[1]  J. Orange,et al.  Viral evasion of natural killer cells , 2002, Nature Immunology.

[2]  P. A. Peterson,et al.  Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. , 1998, Journal of immunology.

[3]  T. Rapoport,et al.  The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate , 1999, The Journal of cell biology.

[4]  G. Ferrara,et al.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Ressing,et al.  Human Cytomegalovirus-Encoded US2 Differentially Affects Surface Expression of MHC Class I Locus Products and Targets Membrane-Bound, but Not Soluble HLA-G1 for Degradation 1 , 2003, The Journal of Immunology.

[6]  T. Rapoport,et al.  Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. , 2001, Molecular biology of the cell.

[7]  P. A. Biro,et al.  Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. , 1988, Journal of immunology.

[8]  K. Früh,et al.  KSHV-K5 inhibits phosphorylation of the major histocompatibility complex class I cytoplasmic tail. , 2001, Virology.

[9]  P. J. van den Elsen,et al.  Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. , 2000, Human immunology.

[10]  A. Aiyar,et al.  Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product. , 1993, BioTechniques.

[11]  H. Ploegh,et al.  Human Cytomegalovirus US2 Endoplasmic Reticulum-Lumenal Domain Dictates Association with Major Histocompatibility Complex Class I in a Locus-Specific Manner , 2001, Journal of Virology.

[12]  B. Moss,et al.  An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag , 1991, Journal of virology.

[13]  L. Sun,et al.  Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains , 1997, Journal of virology.

[14]  K. Früh,et al.  A role for MHC class I down‐regulation in NK cell lysis of herpes virus‐infected cells , 2000, European journal of immunology.

[15]  G. Hassink,et al.  Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. , 2001, The Biochemical journal.

[16]  H. Ploegh,et al.  The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.

[18]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[19]  J. Ellwart,et al.  HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. , 2003, Human immunology.

[20]  L. Herzenberg,et al.  Amplification of a gene coding for human T-cell differentiation antigen , 1983, Nature.

[21]  P. Tomasec,et al.  Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141 , 2005, Nature Immunology.

[22]  H. Ploegh,et al.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[24]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[25]  W. Alexander,et al.  The SOCS box: a tale of destruction and degradation. , 2002, Trends in biochemical sciences.

[26]  F. Mami-Chouaib,et al.  Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Melief,et al.  Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. , 1998, Journal of immunology.

[28]  J. Altman,et al.  Analysis of HLA-E Peptide-Binding Specificity and Contact Residues in Bound Peptide Required for Recognition by CD94/NKG2 1 , 2003, The Journal of Immunology.

[29]  M. Mach,et al.  NK Cell Activity During Human Cytomegalovirus Infection Is Dominated by US2–11-Mediated HLA Class I Down-Regulation1 , 2002, The Journal of Immunology.

[30]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[31]  J. Ellwart,et al.  Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis1 , 2000, The Journal of Immunology.

[32]  N. Taylor,et al.  Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. , 1999, Human gene therapy.

[33]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[34]  N. Blom,et al.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. , 1999, Journal of molecular biology.

[35]  D. Wiley,et al.  Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Olive,et al.  Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody. , 1984, Journal of immunology.

[37]  F. Lemonnier,et al.  Transfection of murine LMTK− cells with purified HLA class I genes , 1986, Immunogenetics.

[38]  E. Wiertz,et al.  Amino acid composition of α1/α2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11‐mediated down‐regulation , 2003, European journal of immunology.

[39]  K. Früh,et al.  Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.

[40]  A. Angulo,et al.  Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA‐E expression: impact on target susceptibility to NK cell subsets , 2003, European journal of immunology.

[41]  H. Ploegh,et al.  Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface? , 2000, Human immunology.

[42]  J. Strominger,et al.  Molecular Characterization of Serologic Recognition Sites in the HLA-A2 Molecule Using Oligonucleotide-Generated Site-Specific Mutants , 1989 .

[43]  M. Llano,et al.  HLA‐E‐bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA‐G‐derived nonamer , 1998, European journal of immunology.

[44]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.